nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—ankylosing spondylitis	0.509	1	CpDpCtD
Sumatriptan—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0508	0.144	CbGbCtD
Sumatriptan—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0456	0.129	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—ankylosing spondylitis	0.043	0.122	CbGbCtD
Sumatriptan—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0403	0.114	CbGbCtD
Sumatriptan—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0269	0.076	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0216	0.0611	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0204	0.0576	CbGbCtD
Sumatriptan—ABCG2—Dexamethasone—ankylosing spondylitis	0.0201	0.0569	CbGbCtD
Sumatriptan—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0192	0.0543	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—ankylosing spondylitis	0.0162	0.0458	CbGbCtD
Sumatriptan—ABCB1—Betamethasone—ankylosing spondylitis	0.0125	0.0353	CbGbCtD
Sumatriptan—ABCB1—Prednisolone—ankylosing spondylitis	0.0123	0.0348	CbGbCtD
Sumatriptan—ABCB1—Prednisone—ankylosing spondylitis	0.0116	0.0329	CbGbCtD
Sumatriptan—HTR1B—dura mater—ankylosing spondylitis	0.0109	0.5	CbGeAlD
Sumatriptan—HTR1D—dura mater—ankylosing spondylitis	0.0105	0.484	CbGeAlD
Sumatriptan—ABCB1—Dexamethasone—ankylosing spondylitis	0.00726	0.0205	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—ankylosing spondylitis	0.00583	0.0165	CbGbCtD
Sumatriptan—MAOA—tendon—ankylosing spondylitis	0.000349	0.016	CbGeAlD
Sumatriptan—Eye disorder—Prednisone—ankylosing spondylitis	7.8e-05	0.000672	CcSEcCtD
Sumatriptan—Anxiety—Methylprednisolone—ankylosing spondylitis	7.78e-05	0.000671	CcSEcCtD
Sumatriptan—Drowsiness—Methotrexate—ankylosing spondylitis	7.77e-05	0.00067	CcSEcCtD
Sumatriptan—Depression—Methotrexate—ankylosing spondylitis	7.75e-05	0.000668	CcSEcCtD
Sumatriptan—Flushing—Prednisone—ankylosing spondylitis	7.75e-05	0.000668	CcSEcCtD
Sumatriptan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	7.74e-05	0.000667	CcSEcCtD
Sumatriptan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	7.74e-05	0.000667	CcSEcCtD
Sumatriptan—Discomfort—Triamcinolone—ankylosing spondylitis	7.74e-05	0.000667	CcSEcCtD
Sumatriptan—Discomfort—Methylprednisolone—ankylosing spondylitis	7.72e-05	0.000665	CcSEcCtD
Sumatriptan—Dry mouth—Triamcinolone—ankylosing spondylitis	7.66e-05	0.00066	CcSEcCtD
Sumatriptan—Angioedema—Dexamethasone—ankylosing spondylitis	7.62e-05	0.000657	CcSEcCtD
Sumatriptan—Angioedema—Betamethasone—ankylosing spondylitis	7.62e-05	0.000657	CcSEcCtD
Sumatriptan—Angiopathy—Prednisone—ankylosing spondylitis	7.57e-05	0.000653	CcSEcCtD
Sumatriptan—Conjunctivitis—Methotrexate—ankylosing spondylitis	7.55e-05	0.000651	CcSEcCtD
Sumatriptan—Confusional state—Methylprednisolone—ankylosing spondylitis	7.55e-05	0.000651	CcSEcCtD
Sumatriptan—Immune system disorder—Prednisone—ankylosing spondylitis	7.54e-05	0.00065	CcSEcCtD
Sumatriptan—Malaise—Betamethasone—ankylosing spondylitis	7.52e-05	0.000648	CcSEcCtD
Sumatriptan—Malaise—Dexamethasone—ankylosing spondylitis	7.52e-05	0.000648	CcSEcCtD
Sumatriptan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	7.51e-05	0.000647	CcSEcCtD
Sumatriptan—Oedema—Triamcinolone—ankylosing spondylitis	7.51e-05	0.000647	CcSEcCtD
Sumatriptan—Vertigo—Betamethasone—ankylosing spondylitis	7.5e-05	0.000646	CcSEcCtD
Sumatriptan—Vertigo—Dexamethasone—ankylosing spondylitis	7.5e-05	0.000646	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	7.49e-05	0.000645	CcSEcCtD
Sumatriptan—Syncope—Dexamethasone—ankylosing spondylitis	7.48e-05	0.000645	CcSEcCtD
Sumatriptan—Syncope—Betamethasone—ankylosing spondylitis	7.48e-05	0.000645	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisone—ankylosing spondylitis	7.46e-05	0.000643	CcSEcCtD
Sumatriptan—Infection—Triamcinolone—ankylosing spondylitis	7.46e-05	0.000642	CcSEcCtD
Sumatriptan—Sweating—Methotrexate—ankylosing spondylitis	7.45e-05	0.000642	CcSEcCtD
Sumatriptan—Infection—Methylprednisolone—ankylosing spondylitis	7.44e-05	0.000641	CcSEcCtD
Sumatriptan—Haematuria—Methotrexate—ankylosing spondylitis	7.41e-05	0.000638	CcSEcCtD
Sumatriptan—Shock—Triamcinolone—ankylosing spondylitis	7.38e-05	0.000636	CcSEcCtD
Sumatriptan—Shock—Methylprednisolone—ankylosing spondylitis	7.37e-05	0.000635	CcSEcCtD
Sumatriptan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	7.34e-05	0.000633	CcSEcCtD
Sumatriptan—Loss of consciousness—Betamethasone—ankylosing spondylitis	7.33e-05	0.000632	CcSEcCtD
Sumatriptan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	7.33e-05	0.000632	CcSEcCtD
Sumatriptan—Epistaxis—Methotrexate—ankylosing spondylitis	7.33e-05	0.000632	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisolone—ankylosing spondylitis	7.33e-05	0.000631	CcSEcCtD
Sumatriptan—Tachycardia—Triamcinolone—ankylosing spondylitis	7.32e-05	0.000631	CcSEcCtD
Sumatriptan—Tachycardia—Methylprednisolone—ankylosing spondylitis	7.31e-05	0.00063	CcSEcCtD
Sumatriptan—Skin disorder—Methylprednisolone—ankylosing spondylitis	7.27e-05	0.000627	CcSEcCtD
Sumatriptan—Erythema—Prednisone—ankylosing spondylitis	7.27e-05	0.000626	CcSEcCtD
Sumatriptan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.26e-05	0.000625	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.24e-05	0.000624	CcSEcCtD
Sumatriptan—Convulsion—Dexamethasone—ankylosing spondylitis	7.23e-05	0.000623	CcSEcCtD
Sumatriptan—Convulsion—Betamethasone—ankylosing spondylitis	7.23e-05	0.000623	CcSEcCtD
Sumatriptan—Hypertension—Dexamethasone—ankylosing spondylitis	7.2e-05	0.000621	CcSEcCtD
Sumatriptan—Hypertension—Betamethasone—ankylosing spondylitis	7.2e-05	0.000621	CcSEcCtD
Sumatriptan—Myalgia—Dexamethasone—ankylosing spondylitis	7.1e-05	0.000612	CcSEcCtD
Sumatriptan—Myalgia—Betamethasone—ankylosing spondylitis	7.1e-05	0.000612	CcSEcCtD
Sumatriptan—Anxiety—Betamethasone—ankylosing spondylitis	7.08e-05	0.00061	CcSEcCtD
Sumatriptan—Anxiety—Dexamethasone—ankylosing spondylitis	7.08e-05	0.00061	CcSEcCtD
Sumatriptan—Discomfort—Dexamethasone—ankylosing spondylitis	7.02e-05	0.000605	CcSEcCtD
Sumatriptan—Discomfort—Betamethasone—ankylosing spondylitis	7.02e-05	0.000605	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—ankylosing spondylitis	7.01e-05	0.000604	CcSEcCtD
Sumatriptan—Hypotension—Methylprednisolone—ankylosing spondylitis	7e-05	0.000603	CcSEcCtD
Sumatriptan—Pain—Prednisolone—ankylosing spondylitis	6.98e-05	0.000601	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—ankylosing spondylitis	6.98e-05	0.000601	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	6.84e-05	0.000589	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	6.82e-05	0.000588	CcSEcCtD
Sumatriptan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	6.81e-05	0.000587	CcSEcCtD
Sumatriptan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	6.81e-05	0.000587	CcSEcCtD
Sumatriptan—Oedema—Dexamethasone—ankylosing spondylitis	6.81e-05	0.000587	CcSEcCtD
Sumatriptan—Oedema—Betamethasone—ankylosing spondylitis	6.81e-05	0.000587	CcSEcCtD
Sumatriptan—Infection—Dexamethasone—ankylosing spondylitis	6.77e-05	0.000583	CcSEcCtD
Sumatriptan—Infection—Betamethasone—ankylosing spondylitis	6.77e-05	0.000583	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisone—ankylosing spondylitis	6.74e-05	0.000581	CcSEcCtD
Sumatriptan—Paraesthesia—Triamcinolone—ankylosing spondylitis	6.74e-05	0.000581	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisolone—ankylosing spondylitis	6.73e-05	0.000579	CcSEcCtD
Sumatriptan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	6.72e-05	0.000579	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—ankylosing spondylitis	6.72e-05	0.000579	CcSEcCtD
Sumatriptan—Anaemia—Prednisone—ankylosing spondylitis	6.72e-05	0.000579	CcSEcCtD
Sumatriptan—Shock—Dexamethasone—ankylosing spondylitis	6.7e-05	0.000577	CcSEcCtD
Sumatriptan—Shock—Betamethasone—ankylosing spondylitis	6.7e-05	0.000577	CcSEcCtD
Sumatriptan—Dyspnoea—Triamcinolone—ankylosing spondylitis	6.69e-05	0.000577	CcSEcCtD
Sumatriptan—Nervous system disorder—Betamethasone—ankylosing spondylitis	6.68e-05	0.000575	CcSEcCtD
Sumatriptan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	6.68e-05	0.000575	CcSEcCtD
Sumatriptan—Agitation—Prednisone—ankylosing spondylitis	6.68e-05	0.000575	CcSEcCtD
Sumatriptan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	6.67e-05	0.000575	CcSEcCtD
Sumatriptan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	6.67e-05	0.000575	CcSEcCtD
Sumatriptan—Tachycardia—Dexamethasone—ankylosing spondylitis	6.65e-05	0.000573	CcSEcCtD
Sumatriptan—Tachycardia—Betamethasone—ankylosing spondylitis	6.65e-05	0.000573	CcSEcCtD
Sumatriptan—Angioedema—Prednisone—ankylosing spondylitis	6.64e-05	0.000572	CcSEcCtD
Sumatriptan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	6.58e-05	0.000567	CcSEcCtD
Sumatriptan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	6.58e-05	0.000567	CcSEcCtD
Sumatriptan—Malaise—Prednisone—ankylosing spondylitis	6.55e-05	0.000565	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—ankylosing spondylitis	6.53e-05	0.000563	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—ankylosing spondylitis	6.52e-05	0.000562	CcSEcCtD
Sumatriptan—Syncope—Prednisone—ankylosing spondylitis	6.52e-05	0.000561	CcSEcCtD
Sumatriptan—Tinnitus—Methotrexate—ankylosing spondylitis	6.5e-05	0.00056	CcSEcCtD
Sumatriptan—Urticaria—Prednisolone—ankylosing spondylitis	6.48e-05	0.000559	CcSEcCtD
Sumatriptan—Fatigue—Triamcinolone—ankylosing spondylitis	6.47e-05	0.000558	CcSEcCtD
Sumatriptan—Fatigue—Methylprednisolone—ankylosing spondylitis	6.46e-05	0.000556	CcSEcCtD
Sumatriptan—Pain—Triamcinolone—ankylosing spondylitis	6.42e-05	0.000553	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—ankylosing spondylitis	6.39e-05	0.00055	CcSEcCtD
Sumatriptan—Hypotension—Dexamethasone—ankylosing spondylitis	6.36e-05	0.000548	CcSEcCtD
Sumatriptan—Hypotension—Betamethasone—ankylosing spondylitis	6.36e-05	0.000548	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—ankylosing spondylitis	6.33e-05	0.000545	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—ankylosing spondylitis	6.3e-05	0.000543	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—ankylosing spondylitis	6.3e-05	0.000542	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	6.29e-05	0.000542	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—ankylosing spondylitis	6.27e-05	0.000541	CcSEcCtD
Sumatriptan—Chills—Methotrexate—ankylosing spondylitis	6.26e-05	0.000539	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.2e-05	0.000535	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.2e-05	0.000535	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—ankylosing spondylitis	6.19e-05	0.000533	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—ankylosing spondylitis	6.19e-05	0.000533	CcSEcCtD
Sumatriptan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	6.18e-05	0.000533	CcSEcCtD
Sumatriptan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	6.17e-05	0.000532	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—ankylosing spondylitis	6.16e-05	0.000531	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.12e-05	0.000528	CcSEcCtD
Sumatriptan—Paraesthesia—Betamethasone—ankylosing spondylitis	6.11e-05	0.000527	CcSEcCtD
Sumatriptan—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.11e-05	0.000527	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—ankylosing spondylitis	6.11e-05	0.000527	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—ankylosing spondylitis	6.07e-05	0.000523	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisolone—ankylosing spondylitis	6.01e-05	0.000518	CcSEcCtD
Sumatriptan—Urticaria—Triamcinolone—ankylosing spondylitis	5.96e-05	0.000514	CcSEcCtD
Sumatriptan—Urticaria—Methylprednisolone—ankylosing spondylitis	5.95e-05	0.000513	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—ankylosing spondylitis	5.95e-05	0.000512	CcSEcCtD
Sumatriptan—Body temperature increased—Triamcinolone—ankylosing spondylitis	5.93e-05	0.000511	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—ankylosing spondylitis	5.93e-05	0.000511	CcSEcCtD
Sumatriptan—Oedema—Prednisone—ankylosing spondylitis	5.93e-05	0.000511	CcSEcCtD
Sumatriptan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	5.92e-05	0.00051	CcSEcCtD
Sumatriptan—Decreased appetite—Dexamethasone—ankylosing spondylitis	5.92e-05	0.00051	CcSEcCtD
Sumatriptan—Decreased appetite—Betamethasone—ankylosing spondylitis	5.92e-05	0.00051	CcSEcCtD
Sumatriptan—Infection—Prednisone—ankylosing spondylitis	5.89e-05	0.000508	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	5.88e-05	0.000507	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	5.88e-05	0.000507	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—ankylosing spondylitis	5.87e-05	0.000506	CcSEcCtD
Sumatriptan—Fatigue—Dexamethasone—ankylosing spondylitis	5.87e-05	0.000506	CcSEcCtD
Sumatriptan—Fatigue—Betamethasone—ankylosing spondylitis	5.87e-05	0.000506	CcSEcCtD
Sumatriptan—Shock—Prednisone—ankylosing spondylitis	5.83e-05	0.000503	CcSEcCtD
Sumatriptan—Pain—Dexamethasone—ankylosing spondylitis	5.82e-05	0.000502	CcSEcCtD
Sumatriptan—Pain—Betamethasone—ankylosing spondylitis	5.82e-05	0.000502	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—ankylosing spondylitis	5.82e-05	0.000501	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—ankylosing spondylitis	5.79e-05	0.000499	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—ankylosing spondylitis	5.76e-05	0.000496	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—ankylosing spondylitis	5.73e-05	0.000494	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	5.63e-05	0.000486	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—ankylosing spondylitis	5.61e-05	0.000484	CcSEcCtD
Sumatriptan—Feeling abnormal—Betamethasone—ankylosing spondylitis	5.61e-05	0.000484	CcSEcCtD
Sumatriptan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	5.61e-05	0.000484	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.57e-05	0.00048	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.57e-05	0.00048	CcSEcCtD
Sumatriptan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	5.53e-05	0.000476	CcSEcCtD
Sumatriptan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	5.52e-05	0.000475	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—ankylosing spondylitis	5.48e-05	0.000472	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—ankylosing spondylitis	5.46e-05	0.00047	CcSEcCtD
Sumatriptan—Urticaria—Dexamethasone—ankylosing spondylitis	5.41e-05	0.000466	CcSEcCtD
Sumatriptan—Urticaria—Betamethasone—ankylosing spondylitis	5.41e-05	0.000466	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.4e-05	0.000466	CcSEcCtD
Sumatriptan—Dizziness—Prednisolone—ankylosing spondylitis	5.4e-05	0.000465	CcSEcCtD
Sumatriptan—Asthenia—Triamcinolone—ankylosing spondylitis	5.38e-05	0.000464	CcSEcCtD
Sumatriptan—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.38e-05	0.000464	CcSEcCtD
Sumatriptan—Body temperature increased—Betamethasone—ankylosing spondylitis	5.38e-05	0.000464	CcSEcCtD
Sumatriptan—Abdominal pain—Betamethasone—ankylosing spondylitis	5.38e-05	0.000464	CcSEcCtD
Sumatriptan—Body temperature increased—Dexamethasone—ankylosing spondylitis	5.38e-05	0.000464	CcSEcCtD
Sumatriptan—Asthenia—Methylprednisolone—ankylosing spondylitis	5.37e-05	0.000463	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—ankylosing spondylitis	5.33e-05	0.000459	CcSEcCtD
Sumatriptan—Pruritus—Triamcinolone—ankylosing spondylitis	5.31e-05	0.000458	CcSEcCtD
Sumatriptan—Cough—Methotrexate—ankylosing spondylitis	5.3e-05	0.000457	CcSEcCtD
Sumatriptan—Pruritus—Methylprednisolone—ankylosing spondylitis	5.3e-05	0.000457	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—ankylosing spondylitis	5.26e-05	0.000453	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—ankylosing spondylitis	5.17e-05	0.000445	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—ankylosing spondylitis	5.17e-05	0.000445	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—ankylosing spondylitis	5.17e-05	0.000445	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—ankylosing spondylitis	5.16e-05	0.000444	CcSEcCtD
Sumatriptan—Rash—Prednisolone—ankylosing spondylitis	5.15e-05	0.000443	CcSEcCtD
Sumatriptan—Dermatitis—Prednisolone—ankylosing spondylitis	5.14e-05	0.000443	CcSEcCtD
Sumatriptan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.12e-05	0.000441	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—ankylosing spondylitis	5.11e-05	0.000441	CcSEcCtD
Sumatriptan—Headache—Prednisolone—ankylosing spondylitis	5.11e-05	0.000441	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—ankylosing spondylitis	5.11e-05	0.00044	CcSEcCtD
Sumatriptan—Constipation—Prednisone—ankylosing spondylitis	5.07e-05	0.000437	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—ankylosing spondylitis	5e-05	0.000431	CcSEcCtD
Sumatriptan—Dizziness—Triamcinolone—ankylosing spondylitis	4.96e-05	0.000428	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	4.96e-05	0.000427	CcSEcCtD
Sumatriptan—Dizziness—Methylprednisolone—ankylosing spondylitis	4.95e-05	0.000427	CcSEcCtD
Sumatriptan—Infection—Methotrexate—ankylosing spondylitis	4.92e-05	0.000424	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—ankylosing spondylitis	4.89e-05	0.000421	CcSEcCtD
Sumatriptan—Asthenia—Dexamethasone—ankylosing spondylitis	4.89e-05	0.000421	CcSEcCtD
Sumatriptan—Asthenia—Betamethasone—ankylosing spondylitis	4.89e-05	0.000421	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—ankylosing spondylitis	4.86e-05	0.000419	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	4.85e-05	0.000418	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.85e-05	0.000418	CcSEcCtD
Sumatriptan—Nausea—Prednisolone—ankylosing spondylitis	4.85e-05	0.000418	CcSEcCtD
Sumatriptan—Pruritus—Dexamethasone—ankylosing spondylitis	4.82e-05	0.000415	CcSEcCtD
Sumatriptan—Pruritus—Betamethasone—ankylosing spondylitis	4.82e-05	0.000415	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—ankylosing spondylitis	4.81e-05	0.000415	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	4.79e-05	0.000413	CcSEcCtD
Sumatriptan—Vomiting—Triamcinolone—ankylosing spondylitis	4.77e-05	0.000411	CcSEcCtD
Sumatriptan—Vomiting—Methylprednisolone—ankylosing spondylitis	4.76e-05	0.00041	CcSEcCtD
Sumatriptan—Rash—Triamcinolone—ankylosing spondylitis	4.73e-05	0.000408	CcSEcCtD
Sumatriptan—Dermatitis—Triamcinolone—ankylosing spondylitis	4.73e-05	0.000407	CcSEcCtD
Sumatriptan—Rash—Methylprednisolone—ankylosing spondylitis	4.72e-05	0.000407	CcSEcCtD
Sumatriptan—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.72e-05	0.000406	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—ankylosing spondylitis	4.71e-05	0.000406	CcSEcCtD
Sumatriptan—Headache—Triamcinolone—ankylosing spondylitis	4.7e-05	0.000405	CcSEcCtD
Sumatriptan—Headache—Methylprednisolone—ankylosing spondylitis	4.69e-05	0.000404	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—ankylosing spondylitis	4.69e-05	0.000404	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—ankylosing spondylitis	4.69e-05	0.000404	CcSEcCtD
Sumatriptan—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.66e-05	0.000401	CcSEcCtD
Sumatriptan—Diarrhoea—Betamethasone—ankylosing spondylitis	4.66e-05	0.000401	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—ankylosing spondylitis	4.63e-05	0.000399	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.52e-05	0.000389	CcSEcCtD
Sumatriptan—Dizziness—Betamethasone—ankylosing spondylitis	4.5e-05	0.000388	CcSEcCtD
Sumatriptan—Dizziness—Dexamethasone—ankylosing spondylitis	4.5e-05	0.000388	CcSEcCtD
Sumatriptan—Nausea—Triamcinolone—ankylosing spondylitis	4.46e-05	0.000384	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—ankylosing spondylitis	4.45e-05	0.000383	CcSEcCtD
Sumatriptan—Nausea—Methylprednisolone—ankylosing spondylitis	4.45e-05	0.000383	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—ankylosing spondylitis	4.42e-05	0.000381	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—ankylosing spondylitis	4.41e-05	0.00038	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—ankylosing spondylitis	4.37e-05	0.000376	CcSEcCtD
Sumatriptan—Vomiting—Dexamethasone—ankylosing spondylitis	4.33e-05	0.000373	CcSEcCtD
Sumatriptan—Vomiting—Betamethasone—ankylosing spondylitis	4.33e-05	0.000373	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—ankylosing spondylitis	4.31e-05	0.000371	CcSEcCtD
Sumatriptan—Rash—Betamethasone—ankylosing spondylitis	4.29e-05	0.00037	CcSEcCtD
Sumatriptan—Rash—Dexamethasone—ankylosing spondylitis	4.29e-05	0.00037	CcSEcCtD
Sumatriptan—Dermatitis—Dexamethasone—ankylosing spondylitis	4.29e-05	0.00037	CcSEcCtD
Sumatriptan—Dermatitis—Betamethasone—ankylosing spondylitis	4.29e-05	0.00037	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.28e-05	0.000369	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—ankylosing spondylitis	4.27e-05	0.000368	CcSEcCtD
Sumatriptan—Headache—Dexamethasone—ankylosing spondylitis	4.27e-05	0.000368	CcSEcCtD
Sumatriptan—Headache—Betamethasone—ankylosing spondylitis	4.27e-05	0.000368	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—ankylosing spondylitis	4.25e-05	0.000367	CcSEcCtD
Sumatriptan—Pain—Methotrexate—ankylosing spondylitis	4.24e-05	0.000365	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—ankylosing spondylitis	4.2e-05	0.000362	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—ankylosing spondylitis	4.08e-05	0.000352	CcSEcCtD
Sumatriptan—Diarrhoea—Prednisone—ankylosing spondylitis	4.06e-05	0.00035	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.05e-05	0.000349	CcSEcCtD
Sumatriptan—Nausea—Dexamethasone—ankylosing spondylitis	4.04e-05	0.000349	CcSEcCtD
Sumatriptan—Nausea—Betamethasone—ankylosing spondylitis	4.04e-05	0.000349	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—ankylosing spondylitis	3.94e-05	0.000339	CcSEcCtD
Sumatriptan—Dizziness—Prednisone—ankylosing spondylitis	3.92e-05	0.000338	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—ankylosing spondylitis	3.92e-05	0.000338	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—ankylosing spondylitis	3.92e-05	0.000338	CcSEcCtD
Sumatriptan—Vomiting—Prednisone—ankylosing spondylitis	3.77e-05	0.000325	CcSEcCtD
Sumatriptan—Rash—Prednisone—ankylosing spondylitis	3.74e-05	0.000322	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—ankylosing spondylitis	3.74e-05	0.000322	CcSEcCtD
Sumatriptan—Headache—Prednisone—ankylosing spondylitis	3.72e-05	0.00032	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.65e-05	0.000315	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—ankylosing spondylitis	3.56e-05	0.000306	CcSEcCtD
Sumatriptan—Nausea—Prednisone—ankylosing spondylitis	3.52e-05	0.000304	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—ankylosing spondylitis	3.51e-05	0.000302	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—ankylosing spondylitis	3.39e-05	0.000292	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—ankylosing spondylitis	3.28e-05	0.000282	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—ankylosing spondylitis	3.15e-05	0.000272	CcSEcCtD
Sumatriptan—Rash—Methotrexate—ankylosing spondylitis	3.12e-05	0.000269	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—ankylosing spondylitis	3.12e-05	0.000269	CcSEcCtD
Sumatriptan—Headache—Methotrexate—ankylosing spondylitis	3.1e-05	0.000268	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—ankylosing spondylitis	2.94e-05	0.000254	CcSEcCtD
